Announcements Trials

Browse Landscape

Phase

Phase 2 8 Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urothelial Cancer 1

Interventions

Cisplatin 187 Carboplatin 182 Paclitaxel 177 Docetaxel 145 Cyclophosphamide 129 Dexamethasone 117 pembrolizumab 106 Doxorubicin 103 Bevacizumab 103 Gemcitabine 102 Rituximab 96 Prednisone 87 Fluorouracil 86 Pemetrexed 82 Radiotherapy 77 Vincristine 71 Etoposide 71 Capecitabine 69 Nivolumab 68 Trastuzumab 67 Leucovorin 64 Cytarabine 57 Methotrexate 52 Oxaliplatin 49 atezolizumab 48 Lenalidomide 43 Ipilimumab 40 Filgrastim 40 Bortezomib 39 Sorafenib 38

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Has results × erdafitinib × Clear all

NCT03390504 2026-05-11

THOR

Janssen Research & Development, LLC

Phase 3 Active not recruiting

629 enrolled 32 charts

Urothelial Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡